Get Social With Us

The Other CAR-T Race: Manufacturing

The biosphere is still buzzing about the FDA’s approval of Kymriah – Novartis’ CAR-T treatment for acute lymphoblastic leukemia that, in many ways, marks the true beginning of the cell and gene therapy era. Approvals of other CAR-Ts are expected soon. But behind the scenes, there’s another race going on:...

Read More

Tiffany Rau, Ph.D. and Howard Levine, Ph.D. of BPTC to present at BPI-EAST

Tiffany Rau, Ph.D., Senior Consultant and Howard Levine, Ph.D., President and CEO at BioProcess Technology Consultants will be presenting at BPI-East, September 25-28, 2017, being held at the Hynes Convention Center in Boston, MA. Dr. Rau’s presentation entitled, “Delivering next generation vaccine processes through technology and teamwork” will be given Monday, September 25th in...

Read More

Cheaper Vaccines! Maybe?

I came away from this year’s World Vaccine Congress impressed by two potentially revolutionary technologies that could radically change the cost of vaccines. The first technology, from LimmaTech Biologics AG, is a manufacturing process for producing conjugate vaccines that eliminates the conjugation chemistry steps and further downstream purification by combining the...

Read More

No openings at this time

Thank you for your interest in BioProcess Technology Consultants®. BPTC® has no specific job openings at this time, however, we encourage industry thought leaders and creative individuals who are seeking to leverage their experience and expertise in biopharmaceutical product development and commercialization to contact us....

Read More

You’re a Good Man Charlie B

We can all heave a sigh of relief. With his recent announcement that he will extend Gov. Deval Patrick’s 10-year, $1 billion life sciences development package – by five years and $500 million – Massachusetts Governor Charlie Baker has finally signaled, unequivocally, that he recognizes the importance of biotechnology and...

Read More

Challenges in Forecasting Biopharmaceutical Demand and the Value of Flexibility

By: Tom Ransohoff Presented at: BioProcess International West. 27 Feb – 2 Mar, 2017, San Francisco, CA This presentation reviews approaches to achieving manufacturing flexibility along with thoughts on the value of this flexibility. The challenges in forecasting future volumetric demand for biopharmaceutical products are well known. For years, we have maintained a...

Read More

Case study-CMC challenges when a small biosimilar developer must rely on outsourcing for development and manufacturing

By: Patti Seymour Presented at: Drug Information Association CMC Workshop. 24-26 Apr, 2017, New York, NY This presentation is a case study that explores the CMC and manufacturing challenges facing a small biosimilar developer. Biosimilar market is expected to grow to ~$40 billion by 2020, which is attracting a large field of competitors....

Read More